Burkina Faso vs Ecuador: Prevalence rate of hypertension in men aged 30-79
Burkina Faso
29.1
in 2019
Ecuador
29.2
in 2019
Burkina Faso rank
178th
Ecuador rank
177th
Prevalence rate of hypertension in men aged 30-79 over time
- Burkina Faso
- Ecuador
How they compare
Ecuador currently reports 29.2 against 29.1 in Burkina Faso, a difference of 0.1.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Burkina Faso ahead.
Burkina Faso ranks 178th and Ecuador ranks 177th of 195 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 32.4 | 22.6 | 9.8 | Burkina Faso |
| 2000s | 32.86 | 23.64 | 9.22 | Burkina Faso |
| 2010s | 30.68 | 26.94 | 3.74 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Burkina Faso or Ecuador?
- Ecuador, at 29.2 against 29.1 in Burkina Faso as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Burkina Faso and Ecuador?
- 0.1, with Ecuador ahead.
- How many years of comparable data are there for Burkina Faso and Ecuador?
- 30 years are reported by both, from 1990 to 2019.
- How do Burkina Faso and Ecuador rank globally for prevalence rate of hypertension in men aged 30-79?
- Burkina Faso ranks 178th and Ecuador ranks 177th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.